Latest
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Essential Medicines and Patents
90% of medicines on the World Health Organization’s Model List of Essential Medicines are off-patent, while many low-income countries have no essential medicine patents at all, according to this Geneva Network research paper.
Featured
Overcoming obstacles to medicines access
As the 2020 World Health Assembly re-convenes in Geneva, an international coalition of think tanks urges governments to commit to simple reforms to accelerate access to medicines, including those in the process of being developed for Covid-19.
Why intellectual property rights matter for COVID-19
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Priorities for UK trade liberalisation
As the UK develops its trade policy outside of the EU, it would be a mistake to base its future approach on the one it inherits from the EU.
Watch: How intellectual property rights are helping to beat Covid-19
Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
Una declaración de principios sobre la compra de medicamentos
La siguiente es una declaración de principios sobre la compra de medicamentos emitida en conjunto por centros de estudios de Argentina, Brasil, Chile, Colombia y México.
A statement of principles on medicines procurement
This is a statement of principles on medicines procurement collectively issued by think tanks from Argentina, Brazil, Chile, Colombia and Mexico.
